Patent details

Basic Information

Publication number:

EP2568812

PCT Application Number:

PCT/US/2011/035501

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117810531

PCT Publication Number:

WO/2011/143057

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

French Title of Invention:

INHIBITEURS INÉDITS DE LA PROLYLCARBOXYPEPTIDASE

German Title of Invention:

NEUARTIGE PROLYLCARBOXYPEPTIDASE-HEMMER

SPC Number:

Dates

Filing date:

06/05/2011

Grant date:

26/10/2016

EP Publication Date:

26/10/2016

PCT Publication Date:

17/11/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/03/2013

EP B1 Publication Date:

26/10/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/05/2017

Expiration date:

06/05/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/05/2011

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:

WU Zhicai

Address:

United States (US)

2

Name:

SHI Zhi-Cai

Address:

United States (US)

3

Name:

YANG Cangming

Address:

United States (US)

4

Name:

JIANG Jinlong

Address:

United States (US)

5

Name:

SHEN Dong-Ming

Address:

United States (US)

6

Name:

SHU Min

Address:

United States (US)

7

Name:

HALE Jeffrey, J.

Address:

United States (US)

Priority

Priority Number:

333451 P

Priority Date:

11/05/2010

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 401/04;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages